The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer

Stem Cells International - Egypt
doi 10.1155/2016/2087204
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

C-Met as a Potential Therapeutic Target and Biomarker in Cancer

Therapeutic Advances in Medical Oncology
Oncology
2011English

Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Transgelin in Bladder Cancer: A Potential Biomarker and Therapeutic Target

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

The PREX1/Rac Signaling Axis: Potential as a Biomarker and Therapeutic Target in Breast Cancer

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2015English

Evaluation of CD44 and CD133 as Cancer Stem Cell Markers for Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2012English

Grp78 as a Therapeutic Target for Refractory Head–neck Cancer With CD24−CD44+ Stemness Phenotype

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2013English

sCLU as Prognostic Biomarker and Therapeutic Target in Osteosarcoma

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

O1-19-1Characterization of URST1 as a Biomarker and Therapeutic Target for Lung Cancer and Oral Cancer

Annals of Oncology
MedicineOncologyHematology
2018English

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy